Pfizer Inc at Goldman Sachs Healthcare Conference Transcript
Good morning, everybody. Let's start on time. I hate to penalize people who are on time, especially in the morning. So welcome to day 2 of the Goldman Sachs Healthcare Conference. I hope everyone had a very positive and productive first day experience. Jet lag is kind of a bummer, but off we go.
Very pleased to have Pfizer join us this year, and in particular, a year under the belt of Chief Development Officer, William Pao. William, thank you for joining us.
Thanks for having me.
Unfortunately, Dave Denton, the CFO, couldn't be with us here. So we're really going to focus a lot on the pipeline. I know obviously, for Pfizer and for investor communities, there's a lot of big picture questions here, but I think personally that this can be an interesting snapshot to really focus
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
